PD-166285 hydrate

• Catalog No.: PZ0116
• M. F.: C26H31Cl4N5O3
• M. W.: 603.36804
• Purity: ≥98% (HPLC)

SYNONYMS

• IUPAC name: 6-(2,6-dichlorophenyl)-2-({4-[2-(diethylamino)ethoxy]phenyl}amino)-8-methyl-7H,8H-pyrido[2,3-d]pyrimidin-7-one hydrate dihydrochloride
• IUPAC Traditional name: 6-(2,6-dichlorophenyl)-2-({4-[2-(diethylamino)ethoxy]phenyl}amino)-8-methylpyrido[2,3-d]pyrimidin-7-one hydrate dihydrochloride
• Synonyms: 6-(2,6-Dichlorophenyl)-2-[[4-[2-(diethylamino)ethoxy]phenyl]amino]-8-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one dihydrochloride hydrate

DATABASE IDS

• MDL Number: MFCD17215957

PROPERTIES

• Empirical Formula (Hill Notation): C26H27Cl2N5O2·2HCl
• Purity: ≥98% (HPLC)
• Apperance: yellow powder
• Solubility: DMSO: ≥20 mg/mL
• Solubility: H2O: ≥5 mg/mL
• GHS Signal Word: Danger
• GHS Hazard statements: H301-H413
• European Hazard Symbols: Toxic (T)
• GHS Precautionary statements: P301 + P310
• RID/ADR: UN 2811 6.1/PG 3
• Risk Statements: 25
• Safety Statements: 45
• Storage Temperature: room temp
• Hazard Class: 6.1
• UN Number: 2811
• Packing Group: 3
• German water hazard class: 3

DETAILS

Description (English)

Biochem/physiol Actions
PD-166285 hydrate is a broad spectrum protein tyrosine kinase inhibitor; Src and FGFR kinase inhibitor.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.

Description (简体中文)

Biochem/physiol Actions
PD-166285 hydrate is a broad spectrum protein tyrosine kinase inhibitor; Src and FGFR kinase inhibitor.
Legal Information
Sold for research purposes under agreement from Pfizer Inc.